Recorded total net revenue from the sale of AGGRASTAT ® of $2.8 million during the quarter ended Macompared to $2.6 million for the quarter ended Maand.Recorded total net revenue of $5.7 million during the quarter ended Macompared to $4.9 million for the quarter ended Maand.Haaris Uddin (CPA, B.Comm.) as Chief Financial Officer, effective June 1, 2022. (' Medicure' or the ' Company') (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended March 31, 2022, and is pleased to also announce the appointment of Mr. WINNIPEG, MB, /PRNewswire/ - Medicure Inc.
